Formulary
|
Dermatology prescribing may require use of expensive unlicensed Specials Recommended by the British Association of Dermatologists for Skin Disease |
|
Several medicines in the skin chapter are available for purchase over the counter and may be appropriate for self care. Please consult the local OTC policy for more details. LSCMMG: Over The Counter (OTC) Items That Should Not Be Routinely Prescribed In Primary Care Policy |
| Potassium Permanganate Permitabs® |
|
Formulary
|
**RAG position and advisory notes currently under review. Follow local protocols. Contact your local medicines management team if futher advice is required.** Solution tablets 400mg Primary Care : Potassium permanganate should always be prescribed for a named patient by a primary care prescriber, experienced in the treatment of dermatological conditions and use of potassium permanganate.
Secondary Care:- Potassium permanganate concentrate should always be prescribed for a named patient by a specialist in dermatology, a clinician working under the guidance of a dermatologist, or specialist tissue viability staff only.
Note: A risk assessment must be completed if potassium permanganate is to be used in a patient's home.
Potassium permanganate is for external use only. Oral ingestion can cause fatality due to local inflammatory reactions that block the airways or cause perforations of the gastrointestinal tract, or through toxicity and organ failure. Potassium permanganate is subject to the requirements of Control of Substances Hazardous to Health including: separate storage, additional hazard labelling, and issue only to staff and patients who have been educated to understand its safe use. Accidental ingestion should be treated as a medical emergency.
|
 BAD and NHS England & NHS Improvement guidance on the safe use of potassium permanganate soaks BAD: Potassium permanganate solution soaks NHS Central alerting system |
|
Links
- BAD and NHS England & NHS Improvement guidance on the safe use of potassium permanganate soaks
- BAD and NHS England & NHS Improvement guidance on the safe use of potassium permanganate soaks
- BAD: Potassium permanganate solution soaks
Lancashire and South Cumbria Infant Feeding Network - Diagnosis and Management of Milk Allergy and Intolerance Guideline- LSCMMG: Inflammatory Bowel Disease: High Cost Drugs Commissioning Pathway
- LSCMMG: Primary Care Constipation Guidelines
- MHRA alert: Risk of gas embolism when used in surgery
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- NaPSA - Inadvertent oral administration of potassium permanganate April 2022
- NHS Central alerting system
- NHS England: Patient safety alert Dec 2014
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people